| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/06/2002 | CA2431839A1 Conjugates of glycosylated/galactosylated peptide |
| 06/06/2002 | CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | CA2430924A1 Angiotensin receptor antagonist composition for the treatment of sexual dysfunction associated with hypertension and another condition |
| 06/06/2002 | CA2430489A1 Methods for contemporaneous administration of levamisole and 5-fluorouracil |
| 06/06/2002 | CA2430409A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use |
| 06/06/2002 | CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | CA2430351A1 Human protooncogene and protein encoded therein |
| 06/06/2002 | CA2430346A1 Beautifying foods and drinks and peroral beautifying preparations |
| 06/06/2002 | CA2430343A1 1,4-disubstituted piperazine derivatives useful as uro-selective .alpha.1-adrenoceptor blockers |
| 06/06/2002 | CA2430341A1 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | CA2430334A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2430309A1 Combination of gaba agonists and aldose reductase inhibitors |
| 06/06/2002 | CA2430298A1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | CA2430296A1 Anti-proliferative drugs |
| 06/06/2002 | CA2430280A1 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 06/06/2002 | CA2430199A1 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | CA2430133A1 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 06/06/2002 | CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | CA2430061A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors |
| 06/06/2002 | CA2430010A1 Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
| 06/06/2002 | CA2429892A1 Benzothiophene derivative compounds, process of preparation and use thereof |
| 06/06/2002 | CA2429814A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2429803A1 Neutral and anionic colloidal particles for gene delivery |
| 06/06/2002 | CA2429801A1 Behavior chemotherapy |
| 06/06/2002 | CA2429749A1 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429723A1 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429722A1 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429665A1 Method of making particles for use in a pharmaceutical composition |
| 06/06/2002 | CA2429583A1 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 06/06/2002 | CA2429469A1 Human elongase genes and uses thereof |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2428018A1 Tetrapartate prodrugs |
| 06/06/2002 | CA2427681A1 Dietary composition containing conjugated linoleic acid and calcium for improved health |
| 06/06/2002 | CA2427618A1 Composition containing statins and calcium for improved cardiovascular health |
| 06/06/2002 | CA2427470A1 Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function |
| 06/06/2002 | CA2427465A1 Inhibition of exoprotein production from grampositive bacteria |
| 06/06/2002 | CA2427161A1 Use of bisphosphonates for pain treatment |
| 06/06/2002 | CA2427098A1 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
| 06/06/2002 | CA2422729A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/05/2002 | EP1211319A2 Gene transfer into pancreatic and biliary epithelial cells |
| 06/05/2002 | EP1211313A2 Modulation of PDE11A activity |
| 06/05/2002 | EP1211305A1 Fat compositions |
| 06/05/2002 | EP1211254A1 Process for the preparation of benzoxazine derivatives and intermediates therefor |
| 06/05/2002 | EP1211250A1 C10 taxane derivatives and pharmaceutical compositions |
| 06/05/2002 | EP1211247A1 Acylamino cyclopropane derivatives |
| 06/05/2002 | EP1211245A1 Agents for controlling animal diseases caused by parasites |
| 06/05/2002 | EP1211243A1 Polymorphs of donepezil hydrochloride and process for production |
| 06/05/2002 | EP1210951A2 Combination for treating andropause containing estrogen agonists/antagonists and testosterone |
| 06/05/2002 | EP1210950A1 Composition against Coccidiosis |
| 06/05/2002 | EP1210947A1 Ophthalmic ointments for treating infective eye diseases |
| 06/05/2002 | EP1210946A1 Astringent composition and method of use |
| 06/05/2002 | EP1210944A1 Blood plasma replacement solution |
| 06/05/2002 | EP1210943A1 New use for budesonide and formoterol |
| 06/05/2002 | EP1210941A2 Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS |
| 06/05/2002 | EP1210940A2 Antifatigue composition |
| 06/05/2002 | EP1210939A2 Pharmaceutical compositions comprising paracetamol and L-Cysteine or a precursor thereof |
| 06/05/2002 | EP1210938A1 Remedies for liver regeneration of transplanted liver |
| 06/05/2002 | EP1210937A2 Device for topical treatment of acne and its method of manufacture |
| 06/05/2002 | EP1210933A1 Skin normalizing agents |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210454A1 Antisense modulation of shp-1 expression |
| 06/05/2002 | EP1210439A1 Coxsackie virus-derived vector system for gene transfer |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210430A2 Muc-1 derived peptides |
| 06/05/2002 | EP1210422A2 Human abc2 transporter and uses thereof |
| 06/05/2002 | EP1210357A1 OLIGONUCLEOTIDE N3'$m(7)P5' THIOPHOSPHORAMIDATES: THEIR SYNTHESIS AND USE |
| 06/05/2002 | EP1210354A1 Prodrugs for liver specific drug delivery |
| 06/05/2002 | EP1210353A1 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 06/05/2002 | EP1210350A1 Water soluble sdz-rad esters |
| 06/05/2002 | EP1210349A2 PYRAZOLO 4,3-d]PYRIMIDINES |
| 06/05/2002 | EP1210348A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 06/05/2002 | EP1210347A1 Carbocyclic nucleosides and process for obtaining such |
| 06/05/2002 | EP1210346A2 New active marine alkaloids |
| 06/05/2002 | EP1210345A1 Oxazole ppar antagonists |
| 06/05/2002 | EP1210344A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 06/05/2002 | EP1210343A2 Benzoic acid derivatives and their use as ppar receptor agonists |
| 06/05/2002 | EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 06/05/2002 | EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 06/05/2002 | EP1210339A1 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 06/05/2002 | EP1210338A2 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system |
| 06/05/2002 | EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 06/05/2002 | EP1210329A2 Aminoalkoxy carbazoles and their use as 5-ht ligands |
| 06/05/2002 | EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands |
| 06/05/2002 | EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 06/05/2002 | EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 06/05/2002 | EP1210325A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210320A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210182A1 Permeabilizing biofilms |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1210119A1 Pharmaceutical compositions for oral and topical administration |
| 06/05/2002 | EP1210118A2 Composition comprising a tramadol material and an anticonvulsant drug |
| 06/05/2002 | EP1210117A2 Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 06/05/2002 | EP1210116A2 Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline |
| 06/05/2002 | EP1210115A1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/05/2002 | EP1210109A2 Utilization of an aminopeptidase inhibitor |
| 06/05/2002 | EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation |